Skip to content

Astrana Health, Inc.: 10-Q filed 2019-11-08

What Astrana Health, Inc. reported in its quarterly report filed 2019-11-08 (fiscal Q3 2019): 49 published measures, 137 facts as tagged in accession 0001628280-19-013826.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-08
Fiscal period
fiscal Q3 2019
Accession
0001628280-19-013826 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-30750,244,382USD
At 2018-12-31512,999,049USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-30381,840,344USD
At 2018-12-31106,337,868USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30190,733,968USD
At 2018-12-31180,545,832USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-30230,298,252USD
At 2018-12-31106,891,503USD
At 2018-09-30119,779,499USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-303,704,174USD92
2019-01-01 to 2019-09-307,389,054USD273
2018-07-01 to 2018-09-309,106,397USD92
2018-01-01 to 2018-09-3013,930,954USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-3010,084,821USD273
2018-01-01 to 2018-09-3031,864,880USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-30806,590USD273
2018-01-01 to 2018-09-30867,732USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-07-01 to 2019-09-30156,060,224USD92
2019-01-01 to 2019-09-30381,866,961USD273
2018-07-01 to 2018-09-30166,729,281USD92
2018-01-01 to 2018-09-30413,319,058USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-30173,706,911USD273
2018-01-01 to 2018-09-30-5,373,713USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-60,364,199USD273
2018-01-01 to 2018-09-30-20,248,175USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-3025,177,257USD
At 2018-12-3117,788,203USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-07-01 to 2019-09-3034,643,754shares92
2019-01-01 to 2019-09-3034,555,124shares273
2018-07-01 to 2018-09-3032,917,007shares92
2018-01-01 to 2018-09-3032,672,793shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-07-01 to 2019-09-3037,792,266shares92
2019-01-01 to 2019-09-3037,816,698shares273
2018-07-01 to 2018-09-3038,387,700shares92
2018-01-01 to 2018-09-3038,010,838shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-07-01 to 2019-09-300.11USD/shares92
2019-01-01 to 2019-09-300.21USD/shares273
2018-07-01 to 2018-09-300.28USD/shares92
2018-01-01 to 2018-09-300.43USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2019-07-01 to 2019-09-300.1USD/shares92
2019-01-01 to 2019-09-300.2USD/shares273
2018-07-01 to 2018-09-300.24USD/shares92
2018-01-01 to 2018-09-300.37USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-07-01 to 2019-09-303,682,472USD92
2019-01-01 to 2019-09-306,483,630USD273
2018-07-01 to 2018-09-3014,585,942USD92
2018-01-01 to 2018-09-3023,338,589USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-3012,427,107USD
At 2018-12-3112,721,082USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-3010,066,168USD92
2019-01-01 to 2019-09-3021,487,078USD273
2018-07-01 to 2018-09-3056,577,104USD92
2018-01-01 to 2018-09-3086,428,560USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-30321,360,707USD
At 2018-12-31172,862,792USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-30827,905USD92
2019-01-01 to 2019-09-301,349,933USD273
2018-07-01 to 2018-09-30178,318USD92
2018-01-01 to 2018-09-30374,002USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-30105,195,228USD
At 2018-12-3172,019,647USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-304,353,117USD
At 2018-12-314,481,544USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2019-09-30237,134,772USD
At 2018-12-31185,805,880USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2019-09-30114,166,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-09-3019,731,189USD
At 2018-12-317,127,217USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2019-01-01 to 2019-09-3040,000USD273
2018-01-01 to 2018-09-300USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-30145,994,056USD92
2019-01-01 to 2019-09-30360,379,883USD273
2018-07-01 to 2018-09-30110,152,177USD92
2018-01-01 to 2018-09-30326,890,498USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3034,822,933shares
At 2018-12-3134,578,040shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-09-30231,064,506USD
At 2018-12-31107,636,973USD
At 2018-09-30124,743,087USD
At 2017-12-31118,500,095USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-30165,521,888USD
At 2018-12-31162,723,051USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2019-09-30192,173,964USD
At 2019-06-30186,089,500USD
At 2019-03-31182,376,770USD
At 2018-12-31181,544,152USD
At 2018-09-30185,126,669USD
At 2018-06-30174,815,156USD
At 2018-03-31170,488,143USD
At 2017-12-31164,183,426USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-3013,540,129USD
At 2019-01-019,000,000USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-3013,506,374USD
At 2019-01-018,900,000USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2019-09-30234,149,063USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2019-09-30114,166,305USD
At 2018-12-3186,875,883USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-09-301,633,153USD
At 2018-12-311,205,962USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-3010,495,938USD
At 2018-12-317,385,098USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2019-09-3016,978,405USD
At 2018-12-319,024,235USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-07-01 to 2019-09-3010,738,862USD92
2019-01-01 to 2019-09-3018,952,664USD273
2018-07-01 to 2018-09-3038,625,440USD92
2018-01-01 to 2018-09-3062,208,688USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-307,949,814USD92
2019-01-01 to 2019-09-3030,031,329USD273
2018-07-01 to 2018-09-309,040,336USD92
2018-01-01 to 2018-09-3031,481,810USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-07-01 to 2019-09-304,920,429USD92
2019-01-01 to 2019-09-3013,792,581USD273
2018-07-01 to 2018-09-304,843,037USD92
2018-01-01 to 2018-09-3014,819,627USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-07-01 to 2019-09-304,300,000USD92
2019-01-01 to 2019-09-3012,000,000USD273
2018-07-01 to 2018-09-304,200,000USD92
2018-01-01 to 2018-09-3012,800,000USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,620,485USD92
2019-01-01 to 2019-09-302,831,830USD273
2018-07-01 to 2018-09-30609,203USD92
2018-01-01 to 2018-09-30884,948USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-304,355,166USD92
2019-01-01 to 2019-09-303,949,216USD273
2018-07-01 to 2018-09-30-3,365,722USD92
2018-01-01 to 2018-09-30-881,283USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-185,699USD273
2018-01-01 to 2018-09-307,135,408USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-30999,582USD273
2018-01-01 to 2018-09-30287,332USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-09-30754,998USD273
2018-01-01 to 2018-09-30200,000USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,676,800USD92
2019-01-01 to 2019-09-303,949,665USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,905,076USD273
2018-01-01 to 2018-09-30-4,484,115USD273

Inspect the source

Entity
Astrana Health, Inc. / CIK 0001083446
Captured
2026-09-20T05:20:50.832Z
SEC response SHA-256
24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))